Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The company is betting that the alternative cytotoxic payload in its ADC can overcome resistance in patients who relapse on Enhertu.

New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with ...

Air pollution and herbal medicines could be behind lung cancer in non-smokers, study finds - Researchers say never-smokers ...